1
|
Expression of TMPRSS2:ERG gene fusion in prostate cancer cells is an important prognostic factor for cancer progression.
|
Cancer Biol Ther
|
2007
|
2.97
|
2
|
Prospective multi-institutional study evaluating the performance of prostate cancer risk calculators.
|
J Clin Oncol
|
2011
|
2.21
|
3
|
Assessing individual risk for prostate cancer.
|
J Clin Oncol
|
2007
|
2.13
|
4
|
Utility of serum tumor markers during surveillance for stage I seminoma.
|
Cancer
|
2012
|
2.05
|
5
|
A novel serum marker, total prostate secretory protein of 94 amino acids, improves prostate cancer detection and helps identify high grade cancers at diagnosis.
|
J Urol
|
2006
|
1.71
|
6
|
Utility of incorporating genetic variants for the early detection of prostate cancer.
|
Clin Cancer Res
|
2009
|
1.39
|
7
|
The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma.
|
J Mol Diagn
|
2012
|
1.24
|
8
|
Protein-coding and microRNA biomarkers of recurrence of prostate cancer following radical prostatectomy.
|
Am J Pathol
|
2011
|
1.24
|
9
|
A prospective comparison of MRI-US fused targeted biopsy versus systematic ultrasound-guided biopsy for detecting clinically significant prostate cancer in patients on active surveillance.
|
J Magn Reson Imaging
|
2014
|
1.21
|
10
|
MR imaging-controlled transurethral ultrasound therapy for conformal treatment of prostate tissue: initial feasibility in humans.
|
Radiology
|
2012
|
1.13
|
11
|
MRI-guided transurethral ultrasound therapy of the prostate gland using real-time thermal mapping: initial studies.
|
Urology
|
2010
|
1.12
|
12
|
Analysis of the spatial and temporal accuracy of heating in the prostate gland using transurethral ultrasound therapy and active MR temperature feedback.
|
Phys Med Biol
|
2009
|
1.07
|
13
|
The use of genetic markers to determine risk for prostate cancer at prostate biopsy.
|
Clin Cancer Res
|
2005
|
1.02
|
14
|
miR-221 Is down-regulated in TMPRSS2:ERG fusion-positive prostate cancer.
|
Anticancer Res
|
2011
|
0.99
|
15
|
New variants at 10q26 and 15q21 are associated with aggressive prostate cancer in a genome-wide association study from a prostate biopsy screening cohort.
|
Cancer Biol Ther
|
2011
|
0.98
|
16
|
Variants of the hK2 protein gene (KLK2) are associated with serum hK2 levels and predict the presence of prostate cancer at biopsy.
|
Clin Cancer Res
|
2006
|
0.98
|
17
|
Protective effect of metformin in CD1 mice placed on a high carbohydrate-high fat diet.
|
Biochem Biophys Res Commun
|
2010
|
0.95
|
18
|
Dysregulation of kallikrein-related peptidases in renal cell carcinoma: potential targets of miRNAs.
|
Biol Chem
|
2010
|
0.94
|
19
|
Prostate tissue analysis immediately following magnetic resonance imaging guided transurethral ultrasound thermal therapy.
|
J Urol
|
2007
|
0.89
|
20
|
Xanthogranulomatous cystitis associated with inflammatory bowel disease.
|
Can Urol Assoc J
|
2010
|
0.85
|
21
|
MicroRNA detection in prostate tumors by quantitative real-time PCR (qPCR).
|
J Vis Exp
|
2012
|
0.82
|
22
|
Nomogram prediction for prostate cancer and aggressive prostate cancer at time of biopsy: utilizing all risk factors and tumor markers for prostate cancer.
|
Can J Urol
|
2006
|
0.81
|
23
|
Making sense of prostate specific antigen: improving its predictive value in patients undergoing prostate biopsy.
|
J Urol
|
2006
|
0.80
|
24
|
Canadian Consensus Conference: The FDA decision on the use of 5ARIs.
|
Can Urol Assoc J
|
2012
|
0.80
|
25
|
Variation in patterns of practice in diagnosing screen-detected prostate cancer.
|
BJU Int
|
2004
|
0.79
|
26
|
Whole-transcriptome analysis reveals established and novel associations with TMPRSS2:ERG fusion in prostate cancer.
|
Anticancer Res
|
2012
|
0.78
|
27
|
Capsaicin: a novel radio-sensitizing agent for prostate cancer.
|
Prostate
|
2014
|
0.77
|
28
|
Prostate cancer pathology audits: is central pathology review still warranted?
|
Can J Urol
|
2012
|
0.77
|
29
|
Feasibility and safety of silicone rubber contrast-enhanced microcomputed tomography in evaluating the angioarchitecture of prostatectomy specimens.
|
Transl Oncol
|
2011
|
0.75
|
30
|
Clinical significance of biopsy-derived primary Gleason score among radical prostatectomy candidates with Gleason 7 tumors.
|
Urology
|
2002
|
0.75
|
31
|
Exercise does not counteract the effects of a "westernized" diet on prostate cancer xenografts.
|
Prostate
|
2013
|
0.75
|